<SEC-DOCUMENT>0000950103-23-017614-index.html : 20231218
<SEC-HEADER>0000950103-23-017614.hdr.sgml : 20231218
<ACCEPTANCE-DATETIME>20231218162541
ACCESSION NUMBER:		0000950103-23-017614
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20231218
DATE AS OF CHANGE:		20231218
EFFECTIVENESS DATE:		20231218

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADC Therapeutics SA
		CENTRAL INDEX KEY:			0001771910
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-276110
		FILM NUMBER:		231494110

	BUSINESS ADDRESS:	
		STREET 1:		BIOPOLE
		STREET 2:		ROUTE DE LA CORNICHE 3B
		CITY:			EPALINGES
		STATE:			V8
		ZIP:			1066
		BUSINESS PHONE:		41 21 653 02 00

	MAIL ADDRESS:	
		STREET 1:		BIOPOLE
		STREET 2:		ROUTE DE LA CORNICHE 3B
		CITY:			EPALINGES
		STATE:			V8
		ZIP:			1066
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>dp204064_s8.htm
<DESCRIPTION>FORM S-8
<TEXT>
Document 1 - file: dp204064_s8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5
<SEQUENCE>2
<FILENAME>dp204064_ex0500.htm
<DESCRIPTION>EXHIBIT 5
<TEXT>
Document 2 - file: dp204064_ex0500.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>dp204064_ex2302.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
Document 3 - file: dp204064_ex2302.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>dp204064_exfilingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
Document 4 - file: dp204064_exfilingfees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: image_001.jpg

</DOCUMENT>
</SEC-DOCUMENT>